Company profile for F.I.S. Fabbrica Italiana Sintetici

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

F.I.S. – Fabbrica Italiana Sintetici is a private Italian company that specializes in API production. Custom Synthesis is our core business, which means the exclusive production of intermediates, advanced intermediates and APIs for pharmaceutical companies who will own the NDA. FIS has the capability to provide a wide array of integrated services to the customer, including process research and development, optimization, and ...
F.I.S. – Fabbrica Italiana Sintetici is a private Italian company that specializes in API production. Custom Synthesis is our core business, which means the exclusive production of intermediates, advanced intermediates and APIs for pharmaceutical companies who will own the NDA. FIS has the capability to provide a wide array of integrated services to the customer, including process research and development, optimization, and scale-up facilities to support both validation and commercial launch. FIS also develops and sells a wide range of Generic APIs including anxiolytics, anticonvulsants, antidepressants, analgesics, etc.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Italy
Address
Address
Viale Milano, 26, 36075 Montecchio, Maggiore, Vicenza (Italy)
Telephone
Telephone
+39-044-470-8011
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

CPhI WW Frankfurt

Not Confirmed

envelop Contact Supplier

CPhI WW Frankfurt

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]
“We are building capabilities to stay ahead of the curve, and align with future needs of global healthcare”
This week, SpeakPharma interviews Girish Chovatia, Chairman and Managing Director of Ami Lifesciences. Since its inception in 2006, Ami Lifesciences has emerged as one of the fastest-growing API manufacturers from India, delivering high-quality active pharmaceutical ingredients (APIs) to global partners across more than 60 countries. With a portfolio of 80+ APIs and strong regulatory accreditations, including those from the US Food and Drug Administration (FDA), European Directorate for the Quality of Medicines & HealthCare (EDQM), and the Pharmaceuticals and Medical Devices Agency (PMDA), the company has built a reputation for innovation, reliability, and customer-centricity.Ami Lifesciences’ ability to combine chemistry expertise with forward-looking strategies such as backward integration, custom synthesis, and a growing focus on platform technologies for next-generation therapeutics sets it apart. The company’s state-of-the-art infrastructure, emphasis on regulatory compliance, and quality culture built from the development stage enable it to serve as a trusted partner to leading pharmaceutical companies worldwide.In this interview, Chovatia shares key milestones in Ami Lifesciences’ growth journey, its approach to sustainability and innovation, and vision for expanding into new therapeutic areas and technologies to strengthen their global presence.Ami Lifesciences has grown rapidly since it began API operations in 2006. What have been the key strategic decisions or turning points that have fueled this growth?When we started API operations in 2006, we knew we were entering a highly competitive, globalized market. The key turning points in our journey were rooted in making bold but carefully thought-out strategic decisions. The first was building a quality-first culture from day one. We invested early in strong regulatory systems, which allowed us to secure approvals from agencies like FDA, EDQM and, PMDA, opening global markets.Another major factor was our focus on complex chemistry and high-barrier molecules. Instead of competing only in crowded, generic APIs, we decided to differentiate ourselves by developing technically challenging products where our chemistry expertise could shine.We also expanded our global footprint quickly, entering over 60 countries with a diverse product portfolio. Partnerships with leading pharmaceutical companies gave us both credibility and growth momentum. Each milestone—from our first CEP approval to our first FDA clearance—strengthened our foundation.Most importantly, we built a team that believes in long-term value creation, not shortcuts. That culture of quality, innovation, and customer trust continues to fuel our growth.HIGHLIGHTS// Building quality-first culture/focus on complex chemistry/expanding global footprint/belief in long-term value creationWith 80 APIs and a presence in more than 60 countries, how does Ami Lifesciences ensure regulatory compliance and maintain quality standards across such a diverse global footprint?For us, regulatory compliance is not just a requirement—it is the backbone of our credibility. We’ve built a quality culture that starts from the development stage itself. Our dedicated DQA (Development Quality Assurance) and DRA (Development Regulatory Affairs) teams are involved right from early R&D, ensuring that every molecule is designed with regulatory expectations in mind.All our facilities operate under stringent cGMP (current good manufacturing practices) conditions and are routinely audited by leading authorities, including the FDA, EDQM, PMDA, and multiple global partners. We have built robust systems for documentation, training, and monitoring that keep compliance non-negotiable.Equally important is the mindset—we train our teams to think “compliance-first” in every activity, big or small. Whether it’s a lab scientist, a production engineer, or a QA associate, everyone knows that quality and compliance are paramount.This integration of systems, people and, culture ensures that no matter which market we serve—be it the US, Europe, Japan, or emerging economies—our partners receive products of consistently high standards.HIGHLIGHTS// Compliance backbone of credibility/stringent cGMP conditions/‘compliance-first mindset’/consistency in high standardsHow does Ami Lifesciences’ backward integration across key molecules strengthen cost competitiveness and supply chain assurance for its global clients?Backward integration has been a conscious strategy for us. In today’s environment, customers not only seek high-quality APIs but also security of supply and cost competitiveness. By investing in in-house development and manufacture of key intermediates, we reduce dependency on external vendors and volatile supply chains.This gives us multiple advantages. First, it brings down costs and improves pricing stability, making us a more competitive partner globally. Second, it gives us greater control over timelines—something our clients value tremendously, especially in regulated markets. And third, it ensures resilience; even during global disruptions. We can assure our partners of uninterrupted supply.In a market where reliability is as critical as cost, our backward integration strategy has become a cornerstone of trust and long-term partnerships.HIGHLIGHTS// Backward integration strategy/focus on in-house development/lower costs/control over timelines global footprint/resilience during disruptionsHow is Ami Lifesciences leveraging R&D capabilities and custom synthesis to drive innovation in various therapeutic areas? Our R&D strength has always been at the core of our differentiation. We have over 150 scientists dedicated to developing APIs across complex therapeutic areas such as cardiovascular, anti-diabetic, and central nervous system (CNS) disorders.What sets us apart is our ability to go beyond standard generics. We focus on process innovation—green chemistry, enzymatic applications, and continuous improvement—to make synthesis routes not only cost-effective but also environmentally responsible.Custom synthesis is another pillar. Many of our global partners approach us for tailor-made solutions—whether it’s a new intermediate, a complex chiral molecule, or a high-barrier API. Our flexible R&D infrastructure allows us to design and scale processes efficiently, from grams in the lab to multi-ton manufacturing.By marrying strong chemistry capabilities with customer collaboration, we’ve positioned ourselves as more than a manufacturer—we’re an innovation partner contributing to faster, safer, and more affordable therapies worldwide.HIGHLIGHTS// Strong R&D capabilities/complex therapeutic expertise/green chemistry/custom synthesis solutions/innovation partner for safer therapiesWhat are the next big milestones Ami Lifesciences is targeting in terms of product development and global expansion?Looking ahead, we see the future of Ami Lifesciences in both depth and diversification. On the product side, we are expanding into next-generation therapeutics—with focus areas including oncology APIs, ADC payloads and linkers, short peptides, and select biotechnology platforms. These are high-value, high-science areas where our chemistry expertise and process innovation can create significant impact.We are also investing in platform technologies that can be applied across multiple therapeutic areas, giving us a strategic edge in next-gen molecules.From a global perspective, our milestones include broadening our presence in regulated markets like the US, Europe, and Japan, while simultaneously strengthening our reach in fast-growing markets across Asia, LATAM, and Africa.Our guiding principle is to stay ahead of the curve—building a portfolio and capabilities that align with where global healthcare is heading, not just where it is today.HIGHLIGHTS// Expanding to new-gen therapeutics/investing in platform technologies/broadening presence in regulated markets/staying ahead of the curveCould you elaborate on Ami Lifesciences’ ESG initiatives and how they are integrated into your manufacturing and business strategy?Sustainability is no longer optional—it’s integral to how we do business. At Ami, we’ve made ESG a central pillar of our growth strategy.On the environmental front, we are pioneers in integrating green chemistry and enzymatic applications into our processes. By leveraging biocatalysis, we reduce reliance on harsh chemicals, improve atom economy, and minimize energy usage. Our plants are designed for solvent recovery, water recycling, and energy efficiency, with strong commitments to waste reduction and zero liquid discharge.Socially, we invest heavily in our people and communities. From training and development to ensuring a safe workplace, we believe our people are our greatest asset. Beyond our facilities, we engage in education, healthcare, and environmental initiatives that uplift surrounding communities.On governance, we run with transparency, accountability, and ethics at the forefront. Our systems ensure compliance not just with laws but with global best practices in corporate responsibility.This holistic ESG framework ensures that as we grow, we do so responsibly create value for customers, employees, communities, and the environment alike.HIGHLIGHTS// ESG central to growth strategy/energy and resource efficiency/waste reduction and zero liquid discharge/holistic responsible growthHow does Ami Lifesciences’ manufacturing infrastructure enhance scalability and quality for its clients?Our manufacturing infrastructure is built for both flexibility and scale. Our Karakhadi facility (in Gujarat) is approved by leading agencies such as FDA, EDQM, ANVISA (Brazilian Health Regulatory Agency), NMPA (National Medical Products Administration of China) and KMFDS (Korean Ministry of Food and Drug Safety). Our products are filed in many other regulatory agencies like PMDA of Japan, NMPA of China, Therapeutic Goods Administration of Australia and Health Canada; giving our partners complete confidence in compliance and quality.The facility has multi-purpose production blocks, allowing us to handle diverse chemistries and scale projects seamlessly—from grams in the lab to multi-ton commercial quantities. This scalability is a key advantage for customers looking for a partner that can support them across the product lifecycle.We further strengthen supply reliability through backward integration of intermediates, which secures both cost efficiency and supply assurance.What makes us unique is the way we integrate quality and sustainability into manufacturing. By embedding quality from the development stage and incorporating green chemistry and enzymatic processes, we ensure that our output is not only reliable and compliant but also environmentally responsible.This combination of regulatory strength, scalability, and sustainable practices makes Ami a trusted long-term partner for leading pharma companies worldwide.HIGHLIGHTS// Flexible, scalable manufacturing infrastructure/facility approved by leading regulators/multi-purpose production blocks/quality, sustainability integrated into manufacturing 

Impressions: 85

https://www.pharmacompass.com/speak-pharma/we-are-building-capabilities-to-stay-ahead-of-the-curve-and-align-with-future-needs-of-global-healthcare

PharmaCompass
13 Oct 2025

VLOG #PharmaReel

[Sponsored by another company]
This PharmaReel showcases Coral Drugs, a global partner in end-to-end API manufacturing with more than 27 years of expertise. Supported by vertically integrated cGMP and ISO-compliant facilities, the company is backed by USFDA and EMA certifications, patents, and advanced micronization capabilities.

Impressions: 2174

read-more

DATA COMPILATION #PharmaFlow

[Sponsored by another company]
Global API micronization market set to surge 49% by 2030, led by specialized industry pioneers
Precise particle size control has become the cornerstone of modern pharmaceutical manufacturing. With highly potent active pharmaceutical ingredients (HPAPIs) and complex formulations driving unprecedented demand, micronization technology is no longer optional — it's critical. The market reflects this urgency. The global API micronization market will jump from US$ 2.47 billion in 2024 to US$ 3.68 billion by 2030 — a 49 percent surge driven by a robust 6.84 percent CAGR. What's powering this growth? Strategic innovation by industry leaders. Companies like Munit SA, Lonza, Catalent, Veranova, EUROAPI, AGC Pharma Chemicals, Hovione and Coral Drugs aren't just participating — they're defining the future of pharmaceutical particle engineering. The Micronization Landscape: How leading companies are advancing pharmaceutical particle engineering The API micronization space is being shaped by companies with specialized expertise. Munit’s proprietary fluid jet milling technology brings particle sizes down to the 1-micron level — critical for inhalation therapies. In addition, this technology enables precise control over particle size distribution without mechanical impact, making it ideal for heat-sensitive and high-potency APIs. With decades of hands-on experience, Munit ensures batch-to-batch consistency, scalability from R&D to commercial volumes, and full compliance with GMP standards.  Munit offers high-containment isolators — including glove boxes for R&D and half-suit isolators for larger batches — with industry-leading containment levels, limiting airborne drug exposure to as low as 0.025 micrograms per cubic meter. This makes it particularly well-suited for handling highly potent or sensitive compounds, exceeding the capabilities of other commercial-scale players like Catalent, who typically achieve containment levels of 0.05 micrograms per cubic meter or higher. EUROAPI has taken a broad particle engineering approach, offering both micronization and spray drying across multiple dosage routes — oral, inhaled, and parenteral. AGC Pharma Chemical leverages spray drying and amorphous solid dispersion technologies across small molecules, peptides, ADCs, and oligonucleotides, exemplifying the evolving intersection of particle engineering and modern drug delivery innovation. Coral Drugs delivers cutting-edge technology and customization capabilities that tailor particle sizes to specific client requirements across tablets, injectables, and topicals. This dynamic competitive landscape continues to evolve as companies expand capabilities and form strategic partnerships. This year, Dec Group announced the launch of their cutting-edge Micronization Suite, now operational in Brick, New Jersey, while Lonza joined the Centre for Continuous Manufacturing and Advanced Crystallisation, an international research hub, to develop innovative continuous processing and crystallization solutions. Selecting the right micronization partner: Key success factors In a pharmaceutical landscape increasingly defined by complexity, precision, and speed-to-market, the choice of a micronization partner can significantly influence a drug’s success. Among the players in this space, Munit SA has emerged as a trusted and strategic ally for pharmaceutical companies worldwide. But what exactly sets Munit apart in the micronization market? To begin with, Munit SA brings over 60 years of experience in particle size engineering. This legacy is not just a number; it reflects decades of accumulated knowledge, process refinement, and a deep understanding of how particle size impacts drug performance. In an industry where even minor deviations can compromise efficacy or safety, this level of experience is invaluable. It has delivered over 500 successful micronization projects to more than 150 customers globally. At its core, Munit SA is laser-focused on micronization and milling — not as ancillary services, but as its primary mission. Their facilities are designed for processing high-potency APIs, cytotoxic and cytostatic compounds, non-beta-lactam antibiotics, steroids, and controlled substances under stringent containment protocols. The company also handles inhalation products, peptides, biological drugs, generics, and R&D compounds. Whether it's micronization for ophthalmic formulations, transdermal or oral products, Munit offers a tailored approach. It stands as a world-leading provider of micronization services in inhalation powders with particle sizes of 1-5 microns and specialized oncology applications for small molecules. In an increasingly complex global landscape, Munit SA addresses supply chain challenges through its dual-site operational model, with facilities in Switzerland (Jetpharma SA) and Italy (Microchem S.r.l). This strategic setup mitigates risks from regulatory changes, geopolitical tensions, or environmental disruptions, ensuring continuous production and delivery of critical APIs. This resilience makes Munit a trusted partner for companies prioritizing business continuity. Why pharmaceutical companies choose Munit for advanced micronization and milling Munit’s proprietary MC Jet Mill is a testament to its engineering excellence. For heat-sensitive APIs, Munit’s cryogenic micronization process uses liquid nitrogen to cool materials, preventing thermal degradation and preserving the integrity of delicate molecules. This is particularly valuable for biologics and APIs with low melting points, where stability is paramount. Additionally, Munit’s under containment micronization employs advanced systems to safely handle HPAPIs, protecting both operators and the environment while meeting stringent regulatory standards.  Their co-micronization service, which processes APIs alongside excipients, further enhances formulation stability and solubility, offering innovative solutions for complex drug profiles. These capabilities, executed under Good Manufacturing Practices (GMP), make Munit a reliable choice for pharmaceutical companies seeking precision and quality. While micronization is Munit’s flagship, it offers milling services through an array of technologies, each suited to specific needs. The Pin Mill uses a grinding chamber and particle size reduction is achieved due impact against a high-speed pin rotor, producing sizes from 50 to 150 microns. It’s particularly effective for APIs needing improved flow for tableting, offering precise size control that ensures uniformity. The Quadro Co-Mill excels at soft de-lumping and homogenization, using a conical sieve and impeller to gently process powders without altering primary particle sizes. For tougher materials, the HammerMill C-10 employs hammer bars on a rotor to crush particles. State-of-the-Art Particle Engineering: Munit's strategic innovation push delivers next-gen solutions Munit’s leadership in micronization is underpinned by a deliberate and sustained investment in innovation — aimed at building the next generation of particle size engineering. In response to client challenges with condensation and product degradation, Munit developed a proprietary conditioning system that precisely controls humidity and temperature. Engineered with ergonomic design and fluid dynamics principles, their machine represents a qualitative leap in conditioning. Munit's new AIFA-approved Building C transforms the Italian hub's capacity. Equipped for high potent, toxic, cytotoxic, and cytostatic compounds, alongside hormones, it features cutting-edge safety systems and integrated technologies, enabling broader API processing with precision and compliance. Munit has merged quality assurance and regulatory affairs into one strategic unit, streamlining workflows and enhancing client responsiveness during critical validation phases. This delivers tailored regulatory support and accelerates time-to-market. These initiatives position Munit at the forefront of particle size engineering, where state-of-the-art innovation, regulatory excellence, and client-centric design converge to set new industry standards. Our view The API micronization market is projected to grow 49 percent to US$ 3.68 billion by 2030. In this evolving landscape, companies that combine deep technical expertise with operational resilience are positioned to capture the greatest value. Munit SA exemplifies this winning formula.

Impressions: 6926

https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers

#Phispers by PHARMACOMPASS
10 Sep 2025

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20230822182420/en

BUSINESSWIRE
22 Aug 2023
India woos Italian bulk drug makers to cut dependency on Chinese APIs
India woos Italian bulk drug makers to cut dependency on Chinese APIs

13 Aug 2015

// Raji Reddy Kesireddy THE ECONOMIC TIMES

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/india-woos-italian-bulk-drug-makers-to-cut-dependency-on-chinese-apis/articleshow/48446172.cms

Raji Reddy Kesireddy THE ECONOMIC TIMES
13 Aug 2015

JDMF

read-more
read-more

01

Bromazepam

JDMF

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registration Number : 220MF10166

Registrant's Address : Viale Milano 26 36075 Montecchio Maggiore Vicenza, Italy

Initial Date of Registration : 2008-07-24

Latest Date of Registration : 2010-10-14

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registration Number : 222MF10163

Registrant's Address : Viale Milano 26 36075 Montecchio Maggiore Vicenza, Italy

Initial Date of Registration : 2010-06-02

Latest Date of Registration : 2010-06-02

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registration Number : 226MF10082

Registrant's Address : Viale Milano 26 36075 Montecchio Maggiore Vicenza, Italy

Initial Date of Registration : 2014-05-02

Latest Date of Registration : 2017-03-30

blank

04

Clonazepam

JDMF

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registration Number : 217MF10543

Registrant's Address : Viale Milano 26 36075 Montecchio Maggiore Vicenza, Italy

Initial Date of Registration : 2005-09-09

Latest Date of Registration : 2010-03-17

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registration Number : 221MF10167

Registrant's Address : Viale Milano 26 36075 Montecchio Maggiore Vicenza, Italy

Initial Date of Registration : 2009-07-30

Latest Date of Registration : 2023-02-02

blank

06

Diazepam

JDMF

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registration Number : 217MF10542

Registrant's Address : Viale Milano 26 36075 Montecchio Maggiore Vicenza, Italy

Initial Date of Registration : 2005-09-09

Latest Date of Registration : 2022-12-23

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registration Number : 230MF10165

Registrant's Address : Viale Milano 26 36075 Montecchio Maggiore Vicenza, Italy

Initial Date of Registration : 2018-12-04

Latest Date of Registration : 2018-12-04

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registration Number : 218MF10792

Registrant's Address : Viale Milano 26 36075 Montecchio Maggiore Vicenza, Italy

Initial Date of Registration : 2006-10-06

Latest Date of Registration : 2006-10-06

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registration Number : 224MF10199

Registrant's Address : Viale Milano 26 36075 Montecchio Maggiore Vicenza, Italy

Initial Date of Registration : 2012-10-01

Latest Date of Registration : 2023-02-21

blank

10

Furosemide

JDMF

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registration Number : 217MF10541

Registrant's Address : Viale Milano 26 36075 Montecchio Maggiore Vicenza, Italy

Initial Date of Registration : 2005-09-09

Latest Date of Registration : 2023-11-08

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-more

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registrant Name : Korea Pfizer Pharmaceutical Co., Ltd.

Registration Date : 2011-10-21

Registration Number : Su189-13-ND

Manufacturer Name : FIS Fabbrica Italiana Sintetic...

Manufacturer Address : Via Dovaro, snc - 36045 Lonigo(VI), Italy@Zona Artigianale 11, CH-6995, Madonna del P...

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registrant Name : Samoh Pharmaceutical Co., Ltd.

Registration Date : 2021-04-16

Registration Number : 20210416-209-J-848

Manufacturer Name : FIS Fabbrica Italiana Sintetic...

Manufacturer Address : Viale Milano, 26-36075 MONTECCHIO MAGGIORE (VI), Italy

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registrant Name : Samoh Pharmaceutical Co., Ltd.

Registration Date : 2018-08-24

Registration Number : 20180824-209-J-109

Manufacturer Name : FIS FABBRICA ITALIANA SINTETIC...

Manufacturer Address : Via Massimo D'Antona, 13 - 86039 TERMOLI (CB), Italy

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registrant Name : Samoh Pharmaceutical Co., Ltd.

Registration Date : 2021-05-04

Registration Number : 20210504-209-J-978

Manufacturer Name : FIS Fabbrica Italiana Sintetic...

Manufacturer Address : Viale Milano, 26-36075 MONTECCHIO MAGGIORE (VI), Italy

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registrant Name : Classia Co., Ltd.

Registration Date : 2021-09-16

Registration Number : 20210916-209-J-969

Manufacturer Name : FIS - Fabbrica Italiana Sintet...

Manufacturer Address : Via Dovaro, snc - 36045 Lonigo (VI)

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registrant Name : Bashu Health Korea Co., Ltd.

Registration Date : 2023-06-08

Registration Number : 20210916-209-J-969(A)

Manufacturer Name : FIS Fabbrica Italiana Sintetic...

Manufacturer Address : Via Dovaro, snc-36045 Lonigo (VI), Italy

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registrant Name : Daiichi Sankyo Korea Co., Ltd.

Registration Date : 2023-12-01

Registration Number : Su256-5-ND

Manufacturer Name : FIS Fabbrica Italiana Sintetic...

Manufacturer Address : Viale Milano, 26 Montecchio Maggiore 36075 Italy

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registrant Name : MSD Korea Co., Ltd.

Registration Date : 2009-04-29

Registration Number : Su906-8-ND

Manufacturer Name : FIS-Fabbrica Italiana Sintetic...

Manufacturer Address : Viale Milano, 26 36075 Montecchio Maggiore, Vicenza

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registrant Name : Gilead Sciences Korea Ltd.

Registration Date : 2016-06-29

Registration Number : Su6273-7-ND

Manufacturer Name : FIS - Fabbrica Italiana Sintet...

Manufacturer Address : Viale Milano 26, 36075 Montecchio Maggiore, Vicenza, Italy

blank

10

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

Registrant Name : Samoh Pharmaceutical Co., Ltd.

Registration Date : 2014-09-19

Registration Number : 20140919-127-H-367-16

Manufacturer Name : FIS Fabbrica Italiana Sintetic...

Manufacturer Address : Viale Milano, 26-36075 MONTECCHIO MAGGIORE(VI), Italy_x000D_

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-more

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

NDC Package Code : 52133-0002

Start Marketing Date : 1982-01-01

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

NDC Package Code : 48087-0066

Start Marketing Date : 2010-04-09

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

NDC Package Code : 48087-0138

Start Marketing Date : 2018-11-29

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

NDC Package Code : 52133-0032

Start Marketing Date : 2013-10-03

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

NDC Package Code : 48087-0051

Start Marketing Date : 2010-03-30

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

NDC Package Code : 48087-0052

Start Marketing Date : 2010-03-30

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

NDC Package Code : 48087-4402

Start Marketing Date : 2010-04-12

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

NDC Package Code : 48087-4401

Start Marketing Date : 2010-04-12

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

NDC Package Code : 48087-0129

Start Marketing Date : 2010-04-12

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

10

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

NDC Package Code : 48087-0117

Start Marketing Date : 2015-01-30

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
click full view

VMF

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

LISTED APIs

read-more
read-more
F.I.S. – Fabbrica Italiana Sintetici is a private Italian company that specializes in API production. Custom Synthesis is our core business, which means the exclusive production of intermediates, advanced intermediates and APIs for pharmaceutical companies who will own the NDA. FIS has the capability to provide a wide array of integrated serv...
F.I.S. – Fabbrica Italiana Sintetici is a private Italian company that specializes in API production. Custom Synthesis is our core business, which means the exclusive production of intermediates, advanced intermediates and APIs for pharmaceutical companies who will own the NDA. FIS has the capability to provide a wide array of integrated services to the customer, including process research and development, optimization, and scale-up facilities to support both validation and commercial launch. FIS also develops and sells a wide range of Generic APIs including anxiolytics, anticonvulsants, antidepressants, analgesics, etc.
blank

01

FNCE
Not Confirmed
arrow
arrow
FNCE
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

F.I.S. – Fabbrica Italiana Sintetici is a private Italian company that specializes in API production. Custom Synthesis is our core business, which means the exclusive production of intermediates, advanced intermediates and APIs for pharmaceutical companies who will own the NDA. FIS has the capability to provide a wide array of integrated services to the customer, including process research and development, optimization, and scale-up facilities to support both validation and commercial launch. FIS also develops and sells a wide range of Generic APIs including anxiolytics, anticonvulsants, antidepressants, analgesics, etc.

About the Company : F.I.S. – Fabbrica Italiana Sintetici is a private Italian company that specializes in API production. Custom Synthesis is our core business, which means the exclusive production of interme...

blank
F.I.S. – Fabbrica Italiana Sintetici is a private Italian company that specializes in API production. Custom Synthesis is our core business, which means the exclusive production of intermediates, advanced intermediates and APIs for pharmaceutical companies who will own the NDA. FIS has the capability to provide a wide array of integrated serv...
F.I.S. – Fabbrica Italiana Sintetici is a private Italian company that specializes in API production. Custom Synthesis is our core business, which means the exclusive production of intermediates, advanced intermediates and APIs for pharmaceutical companies who will own the NDA. FIS has the capability to provide a wide array of integrated services to the customer, including process research and development, optimization, and scale-up facilities to support both validation and commercial launch. FIS also develops and sells a wide range of Generic APIs including anxiolytics, anticonvulsants, antidepressants, analgesics, etc.
blank

02

FNCE
Not Confirmed
arrow
arrow
FNCE
Not Confirmed

F.I.S. Fabbrica Italiana Sintetici

F.I.S. – Fabbrica Italiana Sintetici is a private Italian company that specializes in API production. Custom Synthesis is our core business, which means the exclusive production of intermediates, advanced intermediates and APIs for pharmaceutical companies who will own the NDA. FIS has the capability to provide a wide array of integrated services to the customer, including process research and development, optimization, and scale-up facilities to support both validation and commercial launch. FIS also develops and sells a wide range of Generic APIs including anxiolytics, anticonvulsants, antidepressants, analgesics, etc.

About the Company : F.I.S. – Fabbrica Italiana Sintetici is a private Italian company that specializes in API production. Custom Synthesis is our core business, which means the exclusive production of interme...

blank
Thanks to the expertise and skilss of its multi-fucntion team, PHF can globally manage any development project, offering innovative, quick and competitive solutions. PHF works side-by-side with partners and customers through the different process development steps, assigning the projects to the most suitable laboratories for finalization of develop...
Thanks to the expertise and skilss of its multi-fucntion team, PHF can globally manage any development project, offering innovative, quick and competitive solutions. PHF works side-by-side with partners and customers through the different process development steps, assigning the projects to the most suitable laboratories for finalization of development. PHF can support partners and customers according to European, American and Japanese regulations for active pharmaceutical ingredients (APIs) and pharmaceutical finished products registration. The endpoint of these activities is the marketing and sale of the products developed for PHF and the products under contract development.
blank

03

FNCE
Not Confirmed
arrow
arrow
FNCE
Not Confirmed

PHF SA

Thanks to the expertise and skilss of its multi-fucntion team, PHF can globally manage any development project, offering innovative, quick and competitive solutions. PHF works side-by-side with partners and customers through the different process development steps, assigning the projects to the most suitable laboratories for finalization of development. PHF can support partners and customers according to European, American and Japanese regulations for active pharmaceutical ingredients (APIs) and pharmaceutical finished products registration. The endpoint of these activities is the marketing and sale of the products developed for PHF and the products under contract development.

About the Company : Thanks to the expertise and skilss of its multi-fucntion team, PHF can globally manage any development project, offering innovative, quick and competitive solutions. PHF works side-by-side with ...

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact F.I.S. Fabbrica Italiana Sintetici and get a quotation

F.I.S. Fabbrica Italiana Sintetici is a supplier offers 145 products (APIs, Excipients or Intermediates).

Find a price of Chlordiazepoxide bulk with DMF, CEP, JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Clonazepam bulk with DMF, CEP, JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Clotrimazole bulk with DMF, CEP, JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Diazepam bulk with DMF, CEP, JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Furosemide bulk with DMF, CEP, JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Lorazepam bulk with DMF, CEP, JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Rifaximin bulk with DMF, CEP, JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Dorzolamide Hydrochloride bulk with CEP, JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Acetylcysteine bulk with DMF, CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Bromazepam bulk with CEP, JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Carbamazepine bulk with DMF, CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Clomiphene Citrate bulk with DMF, JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Diltiazem Hydrochloride bulk with DMF, CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Esomeprazole Magnesium bulk with DMF, CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Flurazepam bulk with DMF, JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Fosfomycin Trometamol bulk with DMF, CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Gabapentin bulk with DMF, CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Imatinib Mesylate bulk with DMF, CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Indomethacin bulk with DMF, CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Midazolam bulk with CEP, JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Nebivolol bulk with DMF, CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Nifedipine bulk with DMF, CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Nitrazepam bulk with CEP, JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Nitrofurantoin bulk with DMF, CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Oxazepam bulk with DMF, CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Oxcarbazepine bulk with DMF, CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Pentazocine bulk with DMF, JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Progesterone bulk with DMF, CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Quetiapine Hemifumarate bulk with DMF, JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Sulindac bulk with DMF, JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Entacapone bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Olopatadine Hydrochloride bulk with JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Oxcarbazepine bulk with CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Prazepam bulk with CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Testosterone Propionate bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Bazedoxifene Acetate bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Chlordiazepoxide bulk with CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Chlordiazepoxide HCl bulk with CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Clobazam bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Clomiphene Citrate bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Dorzolamide Hydrochloride bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Eletriptan Hydrobromide bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Erlotinib Hydrochloride bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Esomeprazole Magnesium bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Estazolam bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Flunitrazepam bulk with CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Flurazepam Monohydrochloride bulk with CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Fluvastatin Sodium bulk with JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Imatinib Mesylate bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Indomethacin Sodium bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Lansoprazole bulk with JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Midazolam Hydrochloride bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Nilotinib bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Nitrofurantoin bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Olopatadine Hydrochloride bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Prasterone Acetate bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Propofol bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Safinamide Methanesulfonate bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Sitagliptin Phosphate bulk with JDMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Temazepam bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Testosterone Cypionate bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Tramazoline Hydrochloride Monohydrate bulk with CEP offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of ENAMINE AMIDE (FIS0448) bulk with DMF offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of 2,5-Dibromo-1,4-Dimethyl-1H-Imidazole bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of 4-Des-Dimethylaminotetracycline bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Allopurinol bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Benzylhydrazine bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Clobazam bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Clorazepate Dipotassium bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Desipramine Hydrochloride bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Diltiazem Hydrochloride bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Esomeprazole Magnesium bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Flunitrazepam bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Furazolidone bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Piroxicam bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Quazepam bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Quetiapine Hemifumarate bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Solifenacin Succinate bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Terbinafine bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Tetrazepam bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Triamterene bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Trimethobenzamide HCl bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Trimethoprim bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of FIS0127 bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of CALCIUM CHANNEL BLOCKER - RO 40-5967/001 bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN ALTE DI MONTECCHIO MAGGIORE. bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Armodafinil bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Ataluren bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Carbamazepine bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of CAS 654671-77-9 bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Chlordiazepoxide bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Clomiphene Citrate bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Clotrimazole bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Darifenacin Hydrobromide bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Delorazepam bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Diazepam bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Doravirine bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Edoxaban Tosylate bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Efavirenz bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Eletriptan Hydrobromide bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Elvitegravir bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Entacapone bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Estradiol bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Etoricoxib bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Febantel bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Febuxostat bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Finasteride bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Fluralaner bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Fosaprepitant bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Furosemide bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Gabapentin bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Indomethacin bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Ivabradine Hydrochloride bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Lapatinib Ditosylate bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Levothyroxine Sodium bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Marbofloxacin bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Midazolam Maleate bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Mycophenolate Mofetil bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Nelarabine bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Nifedipine bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Nitrofurantoin bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Olopatadine Hydrochloride bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Omecamtiv Mecarbil bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Oxcarbazepine bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Pazopanib Hydrochloride bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Perampanel bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Procarbazine Hydrochloride bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Progesterone bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Ranolazine bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Sitagliptin Phosphate bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Sofosbuvir bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Sotagliflozin bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Sugammadex Sodium bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Sumatriptan bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Temazepam bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Terbinafine Hydrochloride bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Testosterone bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Testosterone Enanthate bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Testosterone Undecanoate bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Trofinetide bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Ulotaront bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Valbenazine Tosylate bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Velpatasvir bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of Vildagliptin bulk offered by F.I.S. Fabbrica Italiana Sintetici

Find a price of TIGOLANER bulk offered by F.I.S. Fabbrica Italiana Sintetici

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty